Rest of year may see rotation if investors shift from tech
US investors are going all-in on vaccines, all-in on President elect Joe Biden and all-in on the electric car but at least one of those wagers could well prove premature. US stocks continued their historic rally last week, and the Dow Jones Industrial Average closed above 30,000 for the first time as one of the strongest months on record drew to a close on Thanksgiving week.
There remains a chance of more economic and market stumbles if the second wave of Covid-19 in the US causes more lockdowns and mass suffering, well before Mr Biden can pass a stimulus or distribute vaccines.
Last week, AstraZeneca became the latest vaccine maker to post promising trial results, even as the British drug giant conceded that there had been some mistakes resulting in lower doses given to some trial participants.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
UBS weighs synthetic risk transfer amid capital boost proposals
Oil settles higher on supply concerns in the Mid-East, economic woes subdue gains
S-Reits falter as investors weigh possibility of zero rate cuts in 2024
CapitaLand Investment posts total revenue of S$650 million for Q1
Europe: Stoxx 600 logs best day in three months as banks shine
US: Stocks rally after strong tech results